Anti- COVID-19 vaccine will be available in January, says SII CEO


By MYBRANDBOOK


Anti- COVID-19 vaccine will be available in January, says SII CEO

Serum Institute of India (SII) CEO, Adar Poonawalla, confirmed that anti COVID vaccine is likely to be available in the country by January 2021 provided approvals from regulatory bodies are available on time.

 

 “Based on the success of the trials in India and the United Kingdom, and if approvals from regulatory bodies are in place in time, then we can expect the vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious,” said Poonawala.

 

The SII, in collaboration with the British-Swedish pharma major AstraZeneca is working to produce the potential COVID-19 vaccine Covishield.

 

Covishield, developed by University of Oxford, is currently in the phase 2/3 clinical trial in the country and will be produced by SII for low-and-middle income countries.

 

Poonawalla said that the vaccine shot has so far been given to thousands of people in India and abroad with zero safety concerns. He, further, added that it will take two to three years to ascertain the long-term effects of the vaccine.

 

The CEO of the world’s largest drug manufacturing firm also said that the firm is in talks with the government over the pricing of the vaccine and assured that it will be made available at a reasonable price. “We are certain that it will be affordable for all,” he said.

 

SII aims to manufacture about 60-70 million doses, and stretch it up to 100 million doses of the vaccine per month.

 

Poonawalla further said, “We should be able to reach there over the next few months. The pharma firm has also entered into a partnership with Gavi, the Vaccine Alliance and the Bill and Melinda Gates Foundation, to speed up the process of manufacturing and delivery of up to 100 million doses of Covid-19 vaccines for India and other third world countries”. 

 E-Magazine 
 VIDEOS  Placeholder image

Copyright www.mybrandbook.co.in @1999-2024 - All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission of Kalinga Digital Media Pvt. Ltd. is prohibited.
Other Initiatives : www.varindia.com | www.spoindia.org